posted
HEE Corporation Unveils New E-Commerce Website
April 22, 2005 15:23:20 (ET)
HUTCHINSON, Kan., April 22, 2005 /PRNewswire-FirstCall via COMTEX/ -- HEE Corporation announced today the launch of its web-based product sales and information site, http://www.hpb84.net . The exclusive international distributor of HPB-84, a nutraceutical (nutritional supplement) developed in India, HEE Corporation (HCCF, Trade) has spent the past year testing and developing the promising remedy for Type II diabetes. The introduction of the website marks the first time HPB-84 has been available for sale to the public.
According to HEE Corporation president Radley Brooks, "Offering HPB-84 for sale is a big move for our company, culminating months of hard work. Ongoing testing is indicating the efficacy of our product, and we decided it was time to make it publicly available for the specific treatment of Type II diabetes. The marketplace interest has been exceptional, and due to the national and international appeal in HPB-84, we believe the best way to serve both our investors and our customers is to enter the market via the worldwide web. Our business plan thus far has centered on R & D., but it's time to add product sales to the mix, at the same time offering new hope to the estimated 18.2 million Americans who suffer from diabetes."
After several months of research, development, and testing, the new website marks the company's initial revenue channel. HPB-84 is sold on the site, with explanatory pages detailing its use and effectiveness. An FAQ page answers common questions dealing with product ingredients, potential side effects and interactions with other supplements and/or medications. The site also includes a recommended dosing calculator to accurately assess an individual user's needs. The calculator is interactive, assuring optimal results based on a customer's specific information.
Additionally, customers will have the opportunity to post their personal experiences with HPB-84. General information concerning testing, availability and corporate information will also be available. The company is completing plans for its upcoming marketing efforts and advertising campaign, and is in the process of identifying potential international distributors and licensed resellers of HPB-84, as well as other future HEE Corporation products.
Domestic pilot project testing of HPB-84 is nearing completion, with preliminary results indicting that regulated consumption of HPB-84 tablets facilitates the decrease of oral diabetic medications or insulin in some subjects.
Testing will be completed by the end of May 2005, with a final report published in June. Earlier testing indicated the ingestion of the raw herbal ingredient of HPB-84 caused a striking reduction in the need for traditional medications.
For additional information concerning HEE Corporation and HPB-84, visit http://www.HEE-Corp.com .
About HEE HEE's headquarters is based in Hutchinson, Kansas. Forward-Looking Statements:
Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially because of factors such as: entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, changes in licensing programs, product price discounts, delays in product development and related product release schedules, sales channel disruption such as the bankruptcy of a major distributor, and reliance on sole source suppliers for key components that could result in delays in product delivery. Also, any of which may cause revenues and income to fall short of anticipated levels; technological shifts; the ability to have access to distribution channels that are controlled by third parties; the risk of unanticipated increased costs; the continued ability to protect the company's intellectual property rights; adverse effects on our business that might result if an unauthorized disclosure of a significant portion of our formula were to occur; the ability to obtain on acceptable terms the right to incorporate in the company's products and services; changes in product and service mix; maturing product life cycles; product sale terms and conditions; the risk that actual or perceived vulnerabilities in our products could adversely affect our revenues; implementation of operating cost structures that align with revenue growth; unavailability of insurance; uninsured losses; adverse results in litigation; unanticipated tax liabilities; the effects of terrorist activity and armed conflict such as disruptions in general economic activity and changes in our operations and security arrangements; the effects of a major earthquake, cyber-attack or other catastrophic event that results in the destruction or disruption of any of our critical business or information technology systems; the level of corporate information technology spending and changes in general economic conditions that affect demand; currency fluctuations; and financial market volatility or other changes affecting the value of our investments that may result in a reduction in carrying value and recognition of losses including impairment charges.
posted
FROM ANOTHER BOARD.....Allow me to share an e-mail sent yesterday (04-26-2005) from Darci Brooks Director of Investor Relations, HEE-Corp.
E-MAIL:
Nice to hear from you again. And thank you for your feedback on the new HPB-84 website. It is very pleasing to us that so many people are happy with it.
Now, to answer your questions. As far as marketing goes, we are under negotiations with a couple of different marketing groups. We are looking at possibly launching an eight month media "blitz" where we will advertise through T.V., radio, airline in-flight videos, newspapers, magazines and a four to seven minute infomercial. We want people to see and hear of us in a multitude of different ways so they won't be able to forget about us!! It is also crucial that we pick the right company to do the marketing for us. One that is highly reputable and one that will give us the biggest bang for our buck. Of course as I said previously, this is all still under negotiation at this time. As soon as we sign a contract we will put out the news about it officially through a press release.
As for a spokesperson, I know that we would like to have a famous face to back up our product. Names have been tossed around but I can not give you a name in particular at this time.
Feel free to stay in touch with me and I will give you the updates that I can as I receive them.
Darci
Darci Brooks Director of Investor Relations HEE Corporation (hccf.PK) www.hee-corp.com darci@hee-corp.com (620)663-3333
Five Appointed to Help Define and Implement Business Strategies
HUTCHINSON, Kan., May 3, 2005 /PRNewswire-FirstCall via COMTEX/ -- HEE Corporation (OTC: HCCF) president Radley Brooks today named five individuals with wide- ranging business, nutritional and scientific backgrounds to the company's newly formed Board of Advisors. The Board will provide counsel to the company in areas of product development, marketing and overall corporate direction.
Named to the Board were Chad Ballinger, Keith Wiese, Arthur Peplow, Tim Palm, and Michael Moy. According to Brooks, "As we move from research, development and testing into product sales, the Board of Advisors will help guide us through the choppy seas growing companies face. The members of the Board have individual expertise in the fundamentals of business and marketing necessary to help HEE-Corporation grow and be successful."
Ballinger lives in Birmingham, Alabama and is a new business sales representative for Sam's Club, involved in marketing and advertising. His background is in corporate communications, including an internship with Smith Barney.
Wiese is one of HEE Corporation's primary share holders. He owns and operates Diversified Enterprises, Inc. in Plattsmouth, Nebraska.
Peplow of Richfield, Minnesota develops nutritional food products. He holds a Master's Degree in Food Science and Technology from the University of Florida.
Palm is an electrical engineer with expertise in product testing, quality assurance and materials handling. He holds a BSEE from the University of Florida and lives in Sarasota.
Moy lives in Courtland, Ohio, and is provider-certified for the Cleveland Clinic & University Hospital Health Care System. He specializes in ICD9 medical billing and coding and is a certified Medicaid and Medicare provider.
HEE Corporation recently announced the launch of its web-based product sales and information site, http://www.hpb84.net . The company is the exclusive international distributor of HPB-84, a nutraceutical remedy for Type II diabetes that the company has spent the past year testing and developing.
The Board of Advisors will provide guidance as HEE Corporation enters its marketing phase, and will help the company select a national/international marketing firm to aid in establishing the HPB-84 brand. HEE Corporation has identified and is negotiating with such firms.
The Board's formation comes at a time when consumer recognition of HEE Corporation and HPB-84 is quickly growing. Over a four-day period last week, (Friday 4-22-05 afternoon through Tuesday 4-26-05), the company's corporate website received 174,000 hits in response to its announcement of HPB-84's availability. About HEE HEE's headquarters is based in Hutchinson, Kansas.
You do realize this is a herbal treatment. Not a cure for diabetes.
They claim that there herbs help in the treatment of type II diabetes like gengsing helps with sexual problems.
This is a good swing stock but they are not a large pharmaceutical company that will produce the next cure for diabetes. But people tend to pass it off as such. They don't even have to have FDA approval to promote this, only there word because it is nothing more then herbs. Not saying anything bad about the company just stating a fact.
-------------------- Invest with your brain not with your heart.
IP: Logged |
GOOD NEWS FROM THE COMPANY I talked to Dari today and this is what I learned.
The "treatment" everyone is concerned about. She said that she is not familar with the rules but that they are "very very carful about what we put out there" She said that they are working with FDA attornies out of New York.
She said the 'test' results would be out in two weeks,maybe sooner. The doctors were compileing the data now.
I asked about the chat with Becker. They talk every week. Becker told her that everyone keeps bothering him about HCCF. She said that he does not want to talk about Hee but his new venture. She went on to say what we all should know that he cannot legally talk about it anyway.
They are very excited about the new PRfirm and that it came highly recomended.
She said that she is very excited about everything and that she now is thinking that the company is going to be bigger than she ever imagined.
And the best for last...
The marketing campain is to begin TOMORROW there will be no press release because when they do one everyone just says "oh well" so they wont bother. and if you dont believe any of this you can call her and ask 620 633 3333
-------------------- I never knew a Nickle was worth so much....
IP: Logged |
posted
09:43 ET HPB-Artery Klenz to serve as an oral supplement for heart disease.
HUTCHINSON, Kan., May 19 /PRNewswire-FirstCall/ -- HEE Corporation Inc. (OTC Bulletin Board: HCCF) announced today the acquisition of a natural oral chelate, or detoxifying agent, designed to inhibit and repair the damaging effects of heart disease. Tentatively named "HPB-Artery Klenz," the metabolic product is intended to offer a preventative solution to cardiovascular dysfunction and provide a potential alternative to coronary bypass surgery. Approximately 40 million Americans suffer from heart disease and nearly 300,000 undergo coronary artery bypass surgery every year. According to HEE Corporation President Radley Brooks, "The addition of Artery Klenz to our product mix will allow the consumer a safe and inexpensive formula for dealing with potential heart disease both before and after it becomes problematic and will help minimize the need for invasive surgical procedures." Manufactured in the United States, HPB-Artery Klenz, "not only has the ability to remove calcium and plaque deposits from narrowed blood vessels, but will also improve metabolic and circulatory functions by removing various toxic metals such as iron, lead, mercury and cadmium," said Brooks. Chelation is a metabolic medical treatment that has the capability of reducing high blood pressure and cholesterol, at the same time helping to eliminate arterial plaque, not only in the heart, but throughout the body. Working in concert with traditional medical techniques and remedies, HPB- Artery Klenz shows promise in making significant strides in the prevention and repair of the damaging effects of heart disease. In April, HEE Corporation announced the launch of its web-based product sales and information site, http://www.hpb84.net . The exclusive international distributor of HPB-84, a nutriceutical developed in India, HEE Corporation has spent the past year testing and developing the promising nutriceuticalfor Type II diabetes. Similarly, HEE Corporation will conduct a thorough testing of HPB-Artery Klenz as the next addition to its product mix of natural products developed for metabolic syndrome. At the conclusion of such scientifically stringent testing, HPB-Artery Klenz will join the HEE Corporation family of naturopathic metabolic remedies for the treatment of catastrophic diseases.
About HEE HEE's headquarters is based in Hutchinson, Kansas.
Forward-Looking Statements: Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially because of factors such as: entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, changes in licensing programs, product price discounts, delays in product development and related product release schedules, sales channel disruption such as the bankruptcy of a major distributor, and reliance on sole source suppliers for key components that could result in delays in product delivery. Also, any of which may cause revenues and income to fall short of anticipated levels; technological shifts; the ability to have access to distribution channels that are controlled by third parties; the risk of unanticipated increased costs; the continued ability to protect the company's intellectual property rights; adverse effects on our business that might result if an unauthorized disclosure of a significant portion of our formula were to occur; the ability to obtain on acceptable terms the right to incorporate in the company's products and services; changes in product and service mix; maturing product life cycles; product sale terms and conditions; the risk that actual or perceived vulnerabilities in our products could adversely affect our revenues; implementation of operating cost structures that align withrevenue growth; unavailability of insurance; uninsured losses; adverse results in litigation; unanticipated tax liabilities; the effects of terrorist activity and armed conflict such as disruptions in general economic activity and changes in our operations and security arrangements; the effects of a major earthquake, cyber-attack or other catastrophic event that results in the destruction or disruption of any of our critical business or information technology systems; the level of corporate information technology spending and changes in general economic conditions that affect demand; currency fluctuations; and financial market volatility or other changes affecting the value of our investments that may result in a reduction in carrying value and recognition of losses including impairment charges. Note to editors: If you are interested in viewing additional information on HEE Corp, please visit the HEE Corp web page at http://www.HEE-Corp.com on HEE Corp's information pages. Web links, telephone numbers and titles were correct at time of publication, but may since have changed. Shareholder and financial information is available at http://www.HEE-Corp.com .
posted
A TOP TEN POSTING FOR TODAY..... from another board
The magnitude of this has the possibility of HCCF shares skyrocketing.
Diabetes is often accompanied by heart enlargement, heart dysfunction and coronary heart disease. Heart disease is the leading cause of death in people with diabetes (SEE THE CONNECTION). I think Hee Corp. has pulled off a hell of a one-two punch in its battle against Type II Diabetes. As of April 28, the World Health Organization estimates 180 million people have type 2 diabetes
IP: Logged |
posted
HEE Corporation Releases Preliminary Information on Pilot Study PR Newswire - May 24, 2005 11:31
Early Results Encouraging as Ten Patients Respond Positively to HPB-84
HUTCHINSON, Kan., May 24, 2005 /PRNewswire-FirstCall via COMTEX/ -- HEE Corporation (OTC: HCCF) announces today that all nine of the original patients plus one additional patient will complete the 90-day pilot study on the effects of its Type II diabetes nutriceutical HPB-84 with positive improvements to their blood glucose levels.
According to HEE Corporation president Radley Brooks, "We are encouraged by both the efficacy and the patient tolerance of the subjects in our HPB-84 study. In essence, we're seeing marked improvement in the treatment of Type II diabetes with a regimen that includes HPB-84."
HEE Corporation has spent the past year testing and developing the promising nutriceutical for those who suffer from Type II diabetes. In April 2005, the company introduced a website that for the first time offered the product for sale to the general public. ( http://www.hpb84.net ). At the same time, a stringent testing program was underway with the goal of determining the overall effectiveness of HPB-84. Ten subjects were selected and on March 1, 2005 entered into a testing protocol designed to test the efficacy of HPB-84. At this point, half the subjects had completed the program, with several reducing the number of HPB-84 tablets taken daily as they reached their FBG (fasting blood glucose) levels earlier than expected. In addition, some of the patients were able to completely stop taking ancillary diabetic medications.
The test subjects will complete their testing regimen on May 27th, and HEE Corporation will release a final report on the effectiveness of its product on June 4. To this point, each subject has tolerated HPB-84 without adverse side effects, save for occasional low blood sugars which required patients to reduce diabetic medications and/or HPB-84. Laboratory safety data indicates no contraindication to continuing with HPB-84.
The http://www.hpb84.net website is a touchstone for those who may benefit from HPB-84. Customers have the opportunity to post their personal experiences with the product, and general information concerning testing, availability and corporate information will also be available.
About HEE
HEE's headquarters is based in Hutchinson, Kansas.
IP: Logged |
posted
This is a scarey stock. It could go up and down from a ome to two pennies for quite a while or it could be huge, if the findings are legit. I am betting on huge. So I will be holding this for the long term.
-------------------- I never knew a Nickle was worth so much....
IP: Logged |
imakmony2005
unregistered
posted
Same long term hold. if i have too.
IP: Logged |
posted
Come on. This is a herbal treatment. There are all kinds of herbal treatments out there for heart disease, stress, immune system, and more then you can say. None of these are making shareholders rich. Doctors are not going to tell there patients to take this. If this was a new break through drug for diabetes II, it would make the drug company a lot of money, but no herb will. The doctors aren't going to write a prescription or even recommend this.
Not sure what people are thinking on this, but its not a cure or a drug. Its a herbal treatment period. Thats one long disclaimer too. But really if your doctor told you you had type II diabetes, would you take the prescription he gave you or fnd a Herb to take?
-------------------- Learn the hard way with pennies
IP: Logged |
imakmony2005
unregistered
posted
What if your doctor told you to smoke weed?? its a herb does great things to the right person. I play it from all side this stock is not going to a buck any time soon but .05 it might.And thats all i need.
IP: Logged |
imakmony2005
unregistered
posted
Good pr today now lets get going.
IP: Logged |
The results of the 66 year old man are great. The comment about him experiencing improvements in neuropathy is, IMO, a bonus, as I have never once heard Hee mention the possibility of this happening, while using HBP-84. It most commonly affects the feet, legs, hands, and arms. The symptoms may include numbness or a loss of sensation, coldness, tingling. Simply stated "Damage to nerves". In people with diabetes, neuropathy is generally caused by high blood sugar levels. Bottom line people, IF Hee has not been diluting shares, and this so called Top-notch marketing firm, "media imPRessions", show thier stuff and do thier job,we are in for a run, and I feel a big one.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Big Grin]](biggrin.gif)
A TOP TEN POSTING FOR TODAY.....
